Aldo Mateo Torracchi Carrasco
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Aldo Mateo Torracchi Carrasco has a total of 15 co-authors. Here are the top co-authors by number of shared publications:
- Johann Franz Radax
Universidad del Azuay
2 shared publications - Blasco Danilo Moscoso Orellana
Universidad del Azuay
1 shared publication - Carla Marina Salgado Castillo
Facultad de Medicina, Universidad del Azuay, 14-008 Cuenca, Ecuador
1 shared publication - Carlos Joaquín Córdova Serrano
Hospital de Especialidades José Carrasco Arteaga
1 shared publication - Diego Patricio Serrano Piedra
Hospital de Especialidades José Carrasco Arteaga
1 shared publication - Esteban Rolando Figueroa Pazos
Hospital Universitario del Río
1 shared publication
Latest Publications
- Open Access
- 1 December 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (4) , 527-536
Revisión narrativa sobre la eficacia de los nuevos dispositivos comerciales para el cribado domiciliario de apnea obstructiva del sueño
Obstructive sleep apnea (OSA) is the most prevalent chronic respiratory disease worldwide. According to some studies, it may affect up to 25% of the global population, with its presentation varying based on age group, sex, nutritional status, ethnicity and other factors. Despite its high prevalence and the significant impact it has on overall health, OSA remains largely underdiagnosed. By general consensus, polysomnography (PSG) is considered the gold standard for the diagnosis and staging of OSA. However, this method is costly, complex and not widely accessible. In this context, new technologies integrating multimodal sensors capable of ambulatory monitoring circadian rhythm, physical activity and sleep structure, among other parameters, are emerging. Their use is increasingly widespread, promising to become innovative tools for large-scale OSA screening and other sleep disorders. Devices such as smartwatches, rings and smartphones have been extensively studied and have demonstrated acceptable capability when compared to PSG, with many achieving a sensitivity (Se) close to 90% and specificity (Sp) of 80%. Despite the advancements implied by the development of these new health technologies, it is important to consider that the capability of these devices varies depending on the specific equipment and the populations studied. Much of this widely available emerging technology lacks external validation or requires further studies; therefore, it is crucial that its use is regulated by governmental institutions, healthcare services, or other independent organizations.
- 1 December 2025
- Published by Asociacion Latinoamericana de Torax in Respirar
- Vol. 17 (4) , 527-536
Open AccessRevisión narrativa sobre la eficacia de los nuevos dispositivos comerciales para el cribado domiciliario de apnea obstructiva del sueño
Obstructive sleep apnea (OSA) is the most prevalent chronic respiratory disease worldwide. According to some studies, it may affect up to 25% of the global population, with its presentation varying based on age group, sex, nutritional status, ethnicity and other factors. Despite its high prevalence and the significant impact it has on overall health, OSA remains largely underdiagnosed. By general consensus, polysomnography (PSG) is considered the gold standard for the diagnosis and staging of OSA. However, this method is costly, complex and not widely accessible. In this context, new technologies integrating multimodal sensors capable of ambulatory monitoring circadian rhythm, physical activity and sleep structure, among other parameters, are emerging. Their use is increasingly widespread, promising to become innovative tools for large-scale OSA screening and other sleep disorders. Devices such as smartwatches, rings and smartphones have been extensively studied and have demonstrated acceptable capability when compared to PSG, with many achieving a sensitivity (Se) close to 90% and specificity (Sp) of 80%. Despite the advancements implied by the development of these new health technologies, it is important to consider that the capability of these devices varies depending on the specific equipment and the populations studied. Much of this widely available emerging technology lacks external validation or requires further studies; therefore, it is crucial that its use is regulated by governmental institutions, healthcare services, or other independent organizations.
- 31 July 2020
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 12 (2) , 98-105
Resultado del tratamiento en pacientes sometidos a ablación percutánea por arritmias supraventriculares en la ciudad de Cuenca, periodo abril 2013 - julio 2018
BACKGROUND: Supraventricular tachycardia is commonly diagnosed in clinical practice, despite having a good prognosis, it can significantly affect the patient’s life quality. Pharmacological treatment does not result in the total absence of the arrhythmia, which is why ablation therapy has become the treatment of choice, due to its high success rate, and for offering a definitive solution. The aim of this study was to determine the frequency of each supraventricular tachycardia type, according to age and sex, the rate of success of percutaneous ablation and its related factors, and the frequency of complications due to the procedure. METHODS: A cross-sectional, descriptive, correlational study was conducted, including 156 patients diagnosed with supraventricular tachycardia and ablated, from five hospitals where the procedure was performed, based on their clinical records. RESULTS: From the 156 patients in this study, 51.9% were women and 48.1% men, the age ranged between 10 and 80 years. The most commonly reported arrhythmias were nodal reentrant tachycardia, atrioventricular reentrant tachycardia and atrial flutter, being the atrioventricular reentrant tachycardia the most frequent of all. The global success rate was 93.5%, no complications were reported, and none of the studied factors had significant statistical association with the success rate. CONCLUSION: Ablation treatment had a high success rate, with cero complications in this study, demonstrating the efficacy and safety of the procedure.
- 31 July 2020
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 12 (2) , 98-105
Resultado del tratamiento en pacientes sometidos a ablación percutánea por arritmias supraventriculares en la ciudad de Cuenca, periodo abril 2013 - julio 2018
BACKGROUND: Supraventricular tachycardia is commonly diagnosed in clinical practice, despite having a good prognosis, it can significantly affect the patient’s life quality. Pharmacological treatment does not result in the total absence of the arrhythmia, which is why ablation therapy has become the treatment of choice, due to its high success rate, and for offering a definitive solution. The aim of this study was to determine the frequency of each supraventricular tachycardia type, according to age and sex, the rate of success of percutaneous ablation and its related factors, and the frequency of complications due to the procedure. METHODS: A cross-sectional, descriptive, correlational study was conducted, including 156 patients diagnosed with supraventricular tachycardia and ablated, from five hospitals where the procedure was performed, based on their clinical records. RESULTS: From the 156 patients in this study, 51.9% were women and 48.1% men, the age ranged between 10 and 80 years. The most commonly reported arrhythmias were nodal reentrant tachycardia, atrioventricular reentrant tachycardia and atrial flutter, being the atrioventricular reentrant tachycardia the most frequent of all. The global success rate was 93.5%, no complications were reported, and none of the studied factors had significant statistical association with the success rate. CONCLUSION: Ablation treatment had a high success rate, with cero complications in this study, demonstrating the efficacy and safety of the procedure.
- Open Access
- 30 November 2017
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 9 (3) , 275-279
Revisión Bibliográfica: El Microbioma Humano
- 30 November 2017
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 9 (3) , 275-279
Open AccessRevisión Bibliográfica: El Microbioma Humano
- Open Access
- 30 November 2017
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 9 (3) , 285-290
Caso Clínico: Uso de Biomodelos Tridimensionales para la Planificación Preoperatoria de Tumores Craneales Fronto - orbitarios
Caso Clínico: Uso de Biomodelos Tridimensionales para la planificación preoperatoria de Tumores Craneales fronto-orbitarios
- 30 November 2017
- Published by Hospital de Especialidades Jose Carrasco Arteaga in Revista Médica Hospital del José Carrasco Arteaga
- Vol. 9 (3) , 285-290
Open AccessCaso Clínico: Uso de Biomodelos Tridimensionales para la Planificación Preoperatoria de Tumores Craneales Fronto - orbitarios
Caso Clínico: Uso de Biomodelos Tridimensionales para la planificación preoperatoria de Tumores Craneales fronto-orbitarios